BRPI0412131A - métodos de tratamento de distúrbios oftálmicos, para evitar hemorragia retìnica, perda de acuidade visual, reduzir exsudatos duros e retardar progressão de dano retìnico - Google Patents
métodos de tratamento de distúrbios oftálmicos, para evitar hemorragia retìnica, perda de acuidade visual, reduzir exsudatos duros e retardar progressão de dano retìnicoInfo
- Publication number
- BRPI0412131A BRPI0412131A BRPI0412131-7A BRPI0412131A BRPI0412131A BR PI0412131 A BRPI0412131 A BR PI0412131A BR PI0412131 A BRPI0412131 A BR PI0412131A BR PI0412131 A BRPI0412131 A BR PI0412131A
- Authority
- BR
- Brazil
- Prior art keywords
- retinal
- methods
- ophthalmic disorders
- loss
- visual acuity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrane Compounds (AREA)
Abstract
"MéTODOS DE TRATAMENTO DE DISTúRBIOS OFTáLMICOS, PARA EVITAR HEMORRAGIA RETìNICA, PEDRA DE ACUIDADE VISUAL, REDUZIR EXSUDATOS DUROS, E RETARDAR PROGRESSãO DE DANO RETìNICO". Composições farmacêuticas que compreendem bases de cumarina e os seus sais são de utilidade para tratar vários distúrbios oftálmicos. O ingrediente ativo inclui cloricromeno ou seu sal de cloridrato.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48370403P | 2003-06-30 | 2003-06-30 | |
PCT/US2004/020739 WO2005004859A1 (en) | 2003-06-30 | 2004-06-28 | Coumarin derivatives for the treatment of ophthalmic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0412131A true BRPI0412131A (pt) | 2006-08-15 |
Family
ID=34061975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0412131-7A BRPI0412131A (pt) | 2003-06-30 | 2004-06-28 | métodos de tratamento de distúrbios oftálmicos, para evitar hemorragia retìnica, perda de acuidade visual, reduzir exsudatos duros e retardar progressão de dano retìnico |
Country Status (11)
Country | Link |
---|---|
US (1) | US20050054586A1 (pt) |
EP (1) | EP1638550A1 (pt) |
JP (1) | JP2007521285A (pt) |
KR (1) | KR20060026901A (pt) |
CN (1) | CN1870989A (pt) |
AU (1) | AU2004255199A1 (pt) |
BR (1) | BRPI0412131A (pt) |
CA (1) | CA2528148A1 (pt) |
MX (1) | MXPA05014143A (pt) |
WO (1) | WO2005004859A1 (pt) |
ZA (1) | ZA200510344B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR059339A1 (es) | 2006-02-09 | 2008-03-26 | Chugai Pharmaceutical Co Ltd | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene |
US20080103103A1 (en) * | 2006-10-30 | 2008-05-01 | Bahram Memarzadeh | Reagents and methods to treat ocular diseases and infection |
WO2009014100A1 (ja) | 2007-07-20 | 2009-01-29 | Chugai Seiyaku Kabushiki Kaisha | p27蛋白質誘導剤 |
RU2362554C2 (ru) * | 2007-09-27 | 2009-07-27 | Екатерина Валентиновна Лопатина | Регенерирующее противовоспалительное средство и способы лечения с помощью этого средства |
CN102190645B (zh) * | 2010-03-18 | 2014-03-05 | 上海中医药大学 | 蛇床子素衍生物及其制备方法和在制备抗乳腺癌药物中的应用 |
EP3133066A1 (en) | 2015-08-21 | 2017-02-22 | Merck Patent GmbH | Hydrophilic compounds for optically active devices |
EP3133065A1 (en) * | 2015-08-21 | 2017-02-22 | Merck Patent GmbH | Compounds for optically active devices |
EP3363793A1 (en) | 2017-02-15 | 2018-08-22 | Merck Patent GmbH | Hydrophobic compounds for optically active devices |
EP3363786A1 (en) | 2017-02-15 | 2018-08-22 | Merck Patent GmbH | Compounds for optically active devices |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3259635A (en) * | 1962-07-26 | 1966-07-05 | Cassella Farbwerke Mainkur Ag | 7-hydroxy coumarin derivative |
US3515721A (en) * | 1967-06-26 | 1970-06-02 | Cassella Farbwerke Mainkur Ag | 3-tertiary-aminoethyl-4-methyl or phenyl-7-ethoxycarbonylmethoxy - halo or mononitro coumarins and congeners |
IT1088554B (it) * | 1977-11-17 | 1985-06-10 | F I D I A Spa | Procedimento sellettivo per la preparazione di derivati della 7-indrossi cumarina |
IT1160365B (it) * | 1978-12-19 | 1987-03-11 | F I D I A Spa | Applicazioni in campo farmacologico e terapeutico dell'8-cloro-3-(beta-dietilamincetil)-4-metil-7-etossi-carbonilmetossicumarina cloridrato preparato allo stato puro mediante procedimento selettivo, con particolare riguardo alla sua azione antiaritmica |
IT1160366B (it) * | 1978-12-19 | 1987-03-11 | F I D I A Spa | Applicazioni in campo farmacologico e terapeutico dell'8-cloro-3(beta-dietilamincetil)-4-metil-7-etossi-carbonilmetossi cumarina cloridrato preparato allo stato puro con procedimento selettivo con particolare riguardo alla sua attivita' anti-aggregante piastrinica |
US4210667A (en) * | 1979-04-19 | 1980-07-01 | Pfizer Inc. | Pharmaceutical preparations containing coumarin carboxylic acid derivatives |
IT1212907B (it) * | 1983-12-21 | 1989-11-30 | Romeo Aurelio | Preparazione di fenoli alogenati |
FI873428A (fi) * | 1986-08-18 | 1988-02-19 | Houston Biotechnology | Oftalmologiska kompositioner foer behandling av nervdegenerationer. |
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
US6242198B1 (en) * | 1996-07-25 | 2001-06-05 | Cambridge Neuroscience, Inc. | Methods of treatment of eye trauma and disorders |
US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
IT1306669B1 (it) * | 1999-06-14 | 2001-10-02 | Fidia Spa | Composizioni farmaceutiche comprendenti 8-cloro-3 (beta-dietilaminoetil) -4-metil-7-etossicarbonilmetossi cumarina base e |
US6331313B1 (en) * | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
US6375972B1 (en) * | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
IT1317356B1 (it) * | 2000-07-31 | 2003-06-16 | Fidia S P A Ora Fidia Farmaceu | Derivati della cumarina e relativi sali, processo per la loropreparazione e loro impiego in campo farmaceutico. |
JP2004517674A (ja) * | 2000-12-29 | 2004-06-17 | ボシュ・アンド・ロム・インコーポレイテッド | 徐放薬物送達装置 |
EP1347742A1 (en) * | 2001-01-03 | 2003-10-01 | Bausch & Lomb Incorporated | Sustained release drug delivery devices with prefabricated permeable plugs |
ES2294043T3 (es) * | 2001-01-03 | 2008-04-01 | BAUSCH & LOMB INCORPORATED | Dispositivos de liberacion prolongada de medicamentos que comprenden nucleos recubiertos de medicamentos. |
US6756058B2 (en) * | 2001-01-03 | 2004-06-29 | Bausch & Lomb Incorporated | Sustained release drug delivery devices with multiple agents |
CA2433528A1 (en) * | 2001-01-26 | 2002-08-01 | Bausch & Lomb Incorporated | Improved process for the production of sustained release drug delivery devices |
WO2002066454A1 (en) * | 2001-02-21 | 2002-08-29 | Sankyo Company, Limited | Chromene derivatives |
-
2004
- 2004-06-24 US US10/876,014 patent/US20050054586A1/en not_active Abandoned
- 2004-06-28 CN CNA2004800186772A patent/CN1870989A/zh active Pending
- 2004-06-28 WO PCT/US2004/020739 patent/WO2005004859A1/en active Application Filing
- 2004-06-28 KR KR1020057025263A patent/KR20060026901A/ko not_active Application Discontinuation
- 2004-06-28 MX MXPA05014143A patent/MXPA05014143A/es not_active Application Discontinuation
- 2004-06-28 CA CA002528148A patent/CA2528148A1/en not_active Abandoned
- 2004-06-28 JP JP2006517741A patent/JP2007521285A/ja active Pending
- 2004-06-28 AU AU2004255199A patent/AU2004255199A1/en not_active Abandoned
- 2004-06-28 BR BRPI0412131-7A patent/BRPI0412131A/pt not_active IP Right Cessation
- 2004-06-28 EP EP04777201A patent/EP1638550A1/en not_active Withdrawn
-
2005
- 2005-12-20 ZA ZA200510344A patent/ZA200510344B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2004255199A1 (en) | 2005-01-20 |
US20050054586A1 (en) | 2005-03-10 |
JP2007521285A (ja) | 2007-08-02 |
CA2528148A1 (en) | 2005-01-20 |
EP1638550A1 (en) | 2006-03-29 |
MXPA05014143A (es) | 2006-02-24 |
CN1870989A (zh) | 2006-11-29 |
WO2005004859A1 (en) | 2005-01-20 |
ZA200510344B (en) | 2006-12-27 |
KR20060026901A (ko) | 2006-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0515931A (pt) | compostos, processo para a sua preparação, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades e utilização desses compostos | |
ATE428401T1 (de) | Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten | |
BRPI0410563B8 (pt) | compostos de pirazol-quinazolina, seus processos de preparação e composições farmacêuticas | |
BR0312000A (pt) | Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, uso dos compostos | |
DOP2008000001A (es) | Oxazolidinonas substituidas y su uso | |
DK1411932T3 (da) | Kombinationsterapi med substituerede oxazolidinoner | |
BRPI0518173B8 (pt) | composições oftálmicas tópicas para tratamento de olho seco e seus usos | |
BRPI0210707B8 (pt) | composição de solução para administração tópica no tratamento de distúrbios alérgicos ou inflamatórios do olho e do nariz e seu método de preparação | |
BRPI0410477A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, método para a profilaxia ou tratamento de uma condição quiral em um mamìfero, formulação farmacêutica, combinação, uso de um composto, e, processo para preparar um composto | |
BR0312232A (pt) | Inibidores de caspases e seus usos | |
BR0208373A (pt) | Inibidores da tirosina cinase | |
MX2008008556A (es) | Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias. | |
ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
DK1546127T3 (da) | Nye pyrimidinamidderivater og anvendelse deraf | |
ATE529417T1 (de) | 3',4',5-trimethoxyflavonderivate als die schleimsekretion stimulierendes mittel, entsprechendes verfahren und pharmazeutische zusammensetzung, die diese enthält | |
RU2008102249A (ru) | Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания | |
BRPI0409884A (pt) | compostos, composições farmacêuticas, método para o tratamento ou porfilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos | |
BRPI0412131A (pt) | métodos de tratamento de distúrbios oftálmicos, para evitar hemorragia retìnica, perda de acuidade visual, reduzir exsudatos duros e retardar progressão de dano retìnico | |
BRPI0409818A (pt) | compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos | |
WO2006042478A8 (fr) | Inhibiteurs de petites molecules de la protease principale des coronavirus, leur preparation et utilisation | |
BRPI0409878A (pt) | compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos | |
SE0002729D0 (sv) | Novel compound form | |
DK1341813T3 (da) | Anvendelse af L-carnitin som stabiliseringsmiddel af proteiner | |
WO2007117272A3 (en) | Methods for treatment of hemorrhagic shock and related disorders | |
ATE428412T1 (de) | Behandlung von augenkrankheiten mit harnstoff und harnstoffderivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6A E 7A ANUIDADE(S) |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. |